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Depression is one of the most commonly occurring disorders that can significantly impact an 
individual’s quality of life and often leads to increased morbidity and mortality. This paper 
reviews the existing literature on the prevalence and impact of major depressive disorder. It 
explores the ongoing issues associated with help-seeking and examines factors that influence 
or impede individuals accessing help. Research about patient preferences, expectations and 
satisfaction with treatment for depression are reviewed in the context of both pharmacotherapy 
and psychotherapy. Limitations of current research, including ongoing discrepancies across the 
literature, are presented, and recommendations for future research are discussed. In particular, 
the work concludes that there should be a greater focus on understanding individual 
perspectives and experiences in more naturalistic community settings, with less emphasis on 
the use of clinical trial data. 
  







Major Depressive Disorder (MDD) is now one of the most common mental health 
disorders in adults across the globe (Cipriani et al., 2018), and is identified as the main 
contributor to the global burden of disease (Gariepy, Honkaniemi, & Quesnel-Vallee, 2016). 
The World Health Organisation (WHO) has reported that globally, approximately 300 
million people suffer from depression (WHO, 2017). This commonly occurring, recurrent 
disorder has a substantial impact on an individual’s quality of life and is linked to a 
diminished and debilitating level of functioning (Gerhards et al., 2011; Kessler & Bromet, 
2013). Given the recurrent nature of depression, it is now more appropriately viewed as a 
chronic disorder rather than an acute illness (Saver, Van-Nguyen, Keppel, & Doescher, 
2007). WHO has now ranked depression as the fourth leading cause of disability worldwide 
and asserts that by 2020, it will be the second leading cause of disability (Kessler & Bromet, 
2013). Depression is also the main contributor to suicide, with approximately 800,000 suicide 
deaths per year, equating to one person every 40 seconds (WHO, 2017). The increasingly 
high rates of depression have resulted in substantial medical, economic and societal costs 
(Anderson & Roy, 2013). 
MDD: Definition and Diagnostic Criteria  
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American 
Psychiatric Association [APA], 2013) categorises MDD as the occurrence of five or more of 
the (nine) following symptoms that have been present during the same 2-week period and 
represent a change from previous functioning: depressed mood most of the day, nearly every 
day; markedly reduced pleasure and/or interest in all, or almost all activities; significant 
weight loss or weight gain (without dieting), or a decrease or increase in appetite; insomnia 
or hypersomnia; psychomotor agitation; fatigue or loss of energy; feelings of worthlessness 
or excessive guilt; reduced ability to think or concentrate and/or indecisiveness; and recurrent 






thoughts of death or suicidal ideation without a specific plan or alternatively a suicide 
attempt, or a specific plan for committing suicide (APA, 2013). The DSM-5 specifies that at 
least one of the symptoms is either depressed mood or a loss of interest and/or pleasure 
(APA, 2013). While specific criteria must be met to receive a formal diagnosis of MDD 
(APA, 2013), individuals may experience a range of depressive symptoms including low self-
esteem, unremitting fatigue, physical malaise, suicide attempts and self-harming behaviours, 
feelings of worthlessness and loss of interest in things, without satisfying criteria for a formal 
diagnosis (McCann, Lubman, & Clark, 2012; Wang, 2018). 
Prevalence of Depression 
Research indicates that specific information about the prevalence and correlates of 
depression does not exist for most countries. However, while the available data indicates that 
there is immense variability in prevalence estimates, other components of depression’s 
epidemiology, such as the age of onset and persistence, are relatively consistent across 
countries (Kessler & Bromet, 2013). A recent Global Burden of Disease study reported that 
the number of Disability Adjusted Life Years attributed to mental disorders increased by over 
37% between 1990 and 2010 (Harvey et al., 2016). During this time, mental health disorders 
replaced musculoskeletal disorders/conditions as the primary reason for absences and 
inability to work (Harvey et al., 2016). Depression is now one of the most commonly 
encountered conditions in primary health care (Saver et al., 2007). 
In 2017, the prevalence of depression among those aged 18 years and older within the 
United States of America (USA) was an estimated 7.1% (National Institute of Mental Health, 
2019). In Australia, 1 in 6 women, and 1 in 8 men will reportedly experience some level of 
depression during their lifetime (BeyondBlue, 2019). Across the globe, depression is 
commonly comorbid with many other psychiatric disorders, including but not limited to 
various anxiety disorders, Substance Use Disorder, Post-Traumatic Stress Disorder and 






Borderline Personality Disorder (Hasin et al., 2018). Research indicates that 85% of 
Australians with depression also experience significant symptoms of anxiety (Tiller, 2013). 
Unsurprisingly, comorbid depression can further reduce levels of functioning, and increase 
impairment and health care use (Tiller, 2013). 
Many people identified as having mental health disorders do not receive treatment. In 
response to the identified ‘treatment gap’, the 2001 World Health Report made ten 
recommendations, including increasing the training of mental health practitioners, making 
treatment for mental health more accessible and making pharmacological drugs more readily 
available (Jorm, Patten, Brugha, & Mojtabai, 2017). It has been suggested that closing the 
‘treatment gap’ should reduce the prevalence of mental health disorders. In a recent review of 
four developed countries (Australia, Canada, England, USA), researchers examined whether 
an increase in treatment provision has led to a decrease in the prevalence of mental health 
disorders (Jorm et al., 2017). The results indicated that despite significant increases in 
treatment delivery, in particular, the prescription of antidepressants, none of the countries 
have observed a reduction in prevalence. More specifically, it was reported that in Australia, 
antidepressant use increased by 352% from 1990 to 2002 (Jorm et al., 2017). This trend has 
steadily continued, with a 95% increase from 2000 to 2011 (Jorm et al., 2017). There has also 
been considerable growth in the resources allocated to mental health care in Australia. For 
example, there has been an increase in the mental health workforce, increased use of 
antidepressants and increased provision of psychological therapies. In turn, this has led to an 
increase in expenses associated with mental illness, with Australian government expenditure 
rising by 178% between 1992 and 2011 (Jorm et al., 2017). In Australia, the annual cost of 
depression is currently estimated to be around $12.6 billion (Harvey et al., 2016).  
 
 






Help-Seeking for Depression  
 Unfortunately, a high proportion of individuals who require psychological help do not 
seek it (Prins, Verhaak, Bensing, & van der Meer, 2008). Studies examining the rates of 
service utilisation for depression report that the difference between the number of individuals 
who needed treatment and the number of individuals who sought professional help ranged 
between 15.9% and 83.9% (Magaard, Seeralan, Schulz, & Brutt, 2017). Furthermore, it is 
estimated that the median untreated rate for depression is 56.3% worldwide (Magaard et al., 
2017). Attempts to understand the patterns of low help-seeking behaviour have consistently 
found reduced service utilisation among males compared to females (Harris et al., 2015). For 
example, in Australia, only 1 in 4 men who experience depression access treatment 
(BeyondBlue, 2019). Despite the above, there is increasing evidence that Australians are 
becoming more open about mental health. For example, between 1995 and 2011, there was a 
significant increase in the number of individuals who reported having, or having had, an issue 
similar to that of a depressed person described in a vignette (Jorm et al., 2017). Similarly, 
Australians also recorded a reduction in the belief that depression is a character weakness 
(Jorm et al., 2017).  
Several factors influence help-seeking behaviours, including individuals not 
recognising themselves as experiencing psychological difficulties, not believing they will see 
substantive change in their problems and general stigma (Prins et al., 2008). Numerous 
psychological models have been developed to explain variations in help-seeking behaviour 
among populations across the globe. These include the Health Belief Model and the Self-
Regulation Model, with the Behavioural Model of Health Services Use explicitly developed 
to explain help-seeking behaviours (Magaard et al., 2017). This model suggests that health 
behaviours are influenced by a range of considerations including an individuals’ 
predisposition to use services, factors that enable or inhibit the use of services, and the degree 






to which they require care (Magaard et al., 2017). In the most recent version of the model, 
individual and contextual characteristics that influence service utilisation and health-related 
outcomes have been distinguished. More specifically, the model asserts that individual and 
contextual factors involve predisposing factors such as age, gender, ethnicity, education and 
family status; enabling factors such as finances; and needs factors such as depression severity 
and/or comorbidity (Anderson, 2008; Magaard et al., 2017).  
Under-Recognition of Depression and Treatment Options 
The increased prevalence of depression and its subsequent implications emphasise the 
importance of early detection and treatment of depression. However, depression often 
remains substantially under-diagnosed and under-treated (Saver et al., 2007). While research 
indicates that early detection and treatment programs can be cost-effective, dissemination of 
such programs has been impeded by a general reluctance on the part of primary care 
practitioners to implement them (Kessler et al., 2003). Research also indicates that the ability 
of non-psychiatric physicians to recognise and diagnose depression can significantly 
influence outcomes, as unrecognised and undiagnosed individuals are often not offered or 
provided treatment for their depression (Cepoiu et al., 2008). Data suggests that the precision 
with which non-psychiatrists successfully recognise depression is low (Tiller, 2013). One 
study reported that amongst those with depression, less than half had their condition 
recognised by their primary care practitioners, even after five years of follow-up (Cepoiu et 
al., 2008). Similarly, in a qualitative study examining the missed opportunity for diagnosis of 
depression, some participants reported frequently missed diagnosis by their practitioner, 
despite experiencing recurrent depression (Saver et al., 2007). There are numerous reasons 
for under-recognition, under-diagnosis and under-treatment of depression, including but not 
limited to inadequate knowledge about diagnostic criteria, insufficient insight into the various 






presentations of mental health disorders, time pressures and thus an inability to detect and 
manage patients with such presentations (Cepoiu et al., 2008).    
Even when successfully diagnosed and evidence-based guideline treatments are 
provided, many individuals do not commence treatment, fully participate in it or complete an 
adequate treatment course (Saver et al., 2007). An individuals’ decision to not initiate or 
complete treatment may result from a myriad of factors, including inadequate health literacy 
and disappointment or dissatisfaction with the treatment offered (Raue, Schulberg, Heo, 
Klimstra, & Bruce, 2009). Research indicates that patients often report that they do not 
receive sufficient information about mental health. For example, Saver and colleagues (2007) 
found that participants who accessed care in both mental health and primary health care 
settings stated that they received limited information from their health care practitioner about 
depression and potential treatment options. These findings are consistent with previous 
literature relating to the shortcomings and deficits in diagnosing and treating depression 
(Saver et al., 2007).  
In some instances, treatments are not offered or used effectively. Australian data from 
one study indicate that of individuals who commenced treatment, only 45% were offered a 
treatment that could be beneficial (Tiller, 2013). Numerous treatments have been developed 
to manage and treat depression. Choosing and recommending the initial treatment type is the 
most fundamental decision health practitioners face in caring for clients with depression 
(Dunlop et al., 2017). In Australia, there is some evidence that practitioners are advocating 
for and providing treatments that are not consistent with clinical practice guidelines (Jorm et 
al., 2017). Clinical guidelines recommend that individuals with depression should initially be 
treated by either evidence-based psychotherapy or pharmacotherapy (Dunlop et al., 2017).  
 
 






Pharmacotherapy: Antidepressant Medications 
Antidepressants, categorised into various classes of drugs with differing mechanisms 
of action, are widely used as a treatment for depression (Cipriani et al., 2018). 
Pharmacotherapeutic treatment (i.e. selective serotonin reuptake inhibitors [SSRIs]) 
predominately affect the serotonin network of the limbic system, such as the amygdala and 
hippocampus (Quidé, Witteveen, El-Hage, Veltman, & Olff, 2012). Antidepressants are now 
the most commonly used medications across the globe. Approximately 10% of Australian 
adults take them each day, at a rate that has more than doubled since 2000 (Davey & Chanen, 
2016). In 2011, Australia had the second-highest (of 23 countries) consumption of 
antidepressants, yet an increase in the prevalence of mental health disorders has continued 
(Jorm et al., 2017). Similarly, within the USA, antidepressants remain the primary treatment 
for individuals experiencing depression, with 81.9% of individuals in 2007 receiving this 
treatment type (Jorm et al., 2017). Moreover, despite international guidelines recommending 
discontinuation of antidepressants 4 - 12 months after remission, antidepressant use is often 
long-term; only about 10% of individuals discontinue antidepressants each year (Bosman et 
al., 2016). It is now recognised that unnecessary continuation of antidepressants can result in 
long-term side-effects for the individual as well as high healthcare costs (Bosman et al., 
2016). 
The efficacy and effectiveness of antidepressants is a longstanding and controversial 
issue, with varying perspectives across the literature. Some researchers postulate that 
antidepressants are the cornerstone of depression treatment and have been proven to 
effectively reduce the severity and impact of depressive symptoms (Ho, Jacob, & 
Tangiisuran, 2017). There is also strong evidence to suggest that antidepressants are effective 
in preventing relapse (Davey & Chanen, 2016). When comparing the effectiveness of 






different antidepressant medications, research reports similar effectiveness; however, the 
side-effects often differ (Winter & Barber, 2013). 
Conversely, other researchers have concluded that the short-term benefits are modest 
and that long-term sustainability and balance of benefits versus harm are under-researched 
(Cipriani et al., 2018). Approximately 30-40% of individuals with depression do not respond 
sufficiently to an adequately performed first-line drug treatment (Oestergaard & Møldrup, 
2011). Furthermore, individuals who do not successfully respond to the first pharmacological 
treatment also have a lower probability of responding to subsequent antidepressant treatment 
(Oestergaard & Møldrup, 2011). The use and consumption of antidepressants has continued 
to rise despite accumulating evidence that they are not as effective as previously thought 
(Davey & Chanen, 2016). Earlier studies reported substantial effect sizes for antidepressants. 
However, recent meta-analyses have reported modest overall effect sizes, albeit higher for 
severe compared with mild depression (Davey & Chanen, 2016). Interestingly, some studies 
even report a significant placebo effect (Rutherford, Wager, & Roose, 2010). 
Considerable work has been undertaken to elucidate why antidepressants appear to be 
failing. The myriad of putative factors includes selective publishing of positive results, the 
identification of unpublished negative trial results and the increasing rate of positive response 
to placebo (Davey & Chanen, 2016). Furthermore, many studies found that depressed 
individuals have concerns about their antidepressant medication or believe that they can 
become addicted. Brown et al. (2005) found that individuals commonly believe their current 
or future health depends on antidepressant medication, but also believe that doctors prescribe 
too many medications (Prins et al., 2008).  
Psychotherapies  
Psychotherapies such as Cognitive Behavioural Therapy (CBT) and Interpersonal 
Psychotherapy have shown to be at least as effective as pharmacotherapy for mild to 






moderate depression (as defined by cut-off scores on depressive symptom inventories; Davey 
& Chanen, 2016; Weitz et al., 2015). Psychotherapies are structured, time-limited therapies 
that primarily aim to directly address and rectify the core features of depression (Davey & 
Chanen, 2016). While psychotherapies are effective, some meta-analyses have shown that 
earlier studies reported inflated effect sizes (Davey & Chanen, 2016). This may have 
occurred as many early therapy trials only analysed participants who completed treatment, 
often only included non-clinical participants, and used non-active control conditions (Davey 
& Chanen, 2016).  
 The APA and British Association for Psychopharmacology guidelines for treating 
depression advise that while psychotherapy may be sufficient for treating mild depression, 
severe depression (i.e., MDD) is best treated with antidepressants (Weitz et al., 2015). This 
recommendation comes from the National Institute of Mental Health Treatment of 
Depression Collaborative Research Program, which found CBT to be less effective than 
medication in the treatment of severe depression (Weitz et al., 2015). Unfortunately, there is 
an increasing propensity to prescribe medications as the sole treatment for depression, 
irrespective of severity. For example, in the USA, psychotherapy is currently being offered 
less often than previously. From 1998 to 2007, the number of individuals with depression 
treated with psychotherapy decreased from 54% to 43% (Davey & Chanen, 2016).  
The continued declining emphasis on psychotherapy training in psychiatry has 
coincided with the expanding and escalating use of pharmacological treatments (Parker, 
Bylett, & Leggett, 2013). For example, general practitioners (GP), the primary prescribers, 
invariably use antidepressants to treat mild depression, while the evidence and clinical 
guidelines recommend that psychological therapy be the first line of treatment (Jorm et al., 
2017). Research also indicates that individuals are less likely to be advised of 
psychotherapies as an option for depression. In their study, Saver and colleagues (2007) 






reported that fewer than half of participants were advised of, or provided with, information 
about psychotherapies as a treatment for depression. Furthermore, no participants recalled 
being advised what psychotherapy treatment options (including CBT) entail (Saver et al., 
2007). The same study reported that only a minority of participants felt they had a say in 
decision-making about treatment options and even when they did, not all felt they had 
sufficient information to make a good choice (Saver et al., 2007).  
The previously well-established, long tradition of medical psychotherapy appears to 
be in decline (Davey & Chanen, 2016). At present, very few doctors have the expertise to 
deliver psychotherapy. This lack of expertise appears to have resulted in GPs and 
psychiatrists advocating for antidepressants rather than psychotherapy as the first-line of 
treatment for depression (Davey & Chanen, 2016). Some researchers contend that 
psychotherapies are the preferred treatment for all patients. They further suggest that 
medication should only be considered in cases of moderate or greater severity, or when 
psychotherapy has been refused or is deemed ineffective (Davey & Chanen, 2016). Factors 
associated with preference for psychotherapy over medication have included female gender, 
greater knowledge of psychotherapy or prior psychotherapy experience, and no recent 
antidepressant treatment (Prims et al., 2008).  
Combination of Pharmacotherapy and Psychotherapy Treatment 
Given that the effects of psychotherapy and medication appear to operate 
independently of one another, research indicates there is an opportunity to concurrently 
administer treatments (Cuijpers et al., 2014). The National Institute for Health and Clinical 
Excellence (NICE) stipulates that individuals with treatment-resistant, high severity or 
recurrent depression should receive a combination of both pharmacological treatment and 
individual CBT (Oestergaard & Møldrup, 2011). 






The combination of medication and psychotherapy is reportedly more effective than 
either treatment alone (Davey & Chanen, 2016). The effect of a combined treatment approach 
compared with placebo is approximately twice that of medication only compared with 
placebo (Davey & Chanen, 2016). Recent research has emphasised the importance of 
combining the two treatment options in more individuals than is done in current clinical 
practice (Cuijpers et al., 2014).  
Preferred Treatment for Depression 
Evidence for the types of treatments individuals with depression prefer varies across 
the literature. However, some studies indicate that an individual’s belief about mental health 
difficulties and the best treatment option vary markedly from the beliefs of health 
professionals (Prins et al., 2008). Thus, individuals with depression may have different 
perceptions about what factors may influence their help-seeking behaviours, what treatments 
will be helpful for them and acceptability and adherence to treatment (Prins et al., 2008). The 
APA guidelines now stipulate that when appropriate and feasible, practitioners should follow 
patient preferences when recommending treatment for depression (Winter & Barber, 2013).  
Individuals who are offered treatments they show a preference for tend to be more 
likely to initiate, engage in and adhere to treatment and develop a better alliance with their 
practitioner (Dunlop et al., 2017). In studies specific to depression, the relationship between 
treatment preference and treatment outcome shows significant variation (Dunlop et al., 2012). 
For example, some studies indicate that individuals who receive their preferred treatment 
have more optimal treatment outcomes than individuals who do not (Dunlop et al., 2012). 
However, other studies have found no evidence to support treatment preference as a predictor 
in depression treatment outcomes (Dunlop et al., 2012). Regardless, treatment preference has 
been identified as an important contributing factor to treatment adherence and attrition. For 
example, meta-analyses have indicated that individuals who do not receive their preferred 






treatment are more likely to cease treatment prematurely (Dunlop et al., 2017). Furthermore, 
some research postulates the importance of using patient preferences for initial treatments 
(Dunlop et al., 2017). Individual preferences are deemed valuable as studies have found that 
those who receive their preferred treatment invest more fully in their treatment (Dunlop et al., 
2017).  
An important potential confounding factor of the impact of preference on outcomes is 
an individuals’ prior treatment exposure (Dunlop et al., 2017). Prior treatment may influence 
an individuals’ willingness to trial particular treatments (Dunlop et al., 2017). Furthermore, 
previous experience with depression treatment, either personally or through a friend or family 
member, has been associated with treatment preference (Winter & Barber, 2013).  
Expectations and Their Role in Mental Health 
 Expectations comprise an individual’s beliefs or cognitions that are future-orientated 
and focused on the occurrence or non-occurrence of an event or experience (Rief & 
Glombiewski, 2017). In the context of treatment for mental health disorders, expectations are 
considered as a “central mechanism of change” (Rief & Glombiewski, 2017, p. 210). Within 
the field of mental health, expectations have previously been divided into either “prognostic 
expectations” or “participant role expectations” (Rutherford et al., 2010, p. 2). Prognostic or 
outcome-oriented expectations relate to anticipated positive and/or adverse effects of 
treatment, and the associated probabilities of various outcomes (Rutherford et al., 2010). Role 
expectations refer to anticipated behaviours on the part of the treating practitioner and 
individual during treatment (Rutherford et al., 2010). 
It is now well established that expectations can have positive or negative impacts on 
treatment outcomes, depending on many factors, including whether or not an individual 
believes that treatment will be beneficial or harmful. Moreover, the impacts can vary in 
strength depending on the rationale for the individual’s expectations (Rutherford et al., 2010). 






Acknowledging and understanding the role and impact of expectations in both 
pharmacotherapeutic and psychotherapeutic treatments is imperative (Rief & Glombiewski, 
2017). Irrespective of the treatment type, expectations about treatment success are the most 
prominent predictor of outcome and can occur at any phase of treatment (i.e. pre, during and 
post; Rief & Glombiewski, 2017; Rutherford et al., 2010). For example, before treatment, 
individuals often develop outcome expectations based on their understanding of their 
disorder, the treatment being offered and any previous treatment experience (Rutherford et 
al., 2010). During treatment, expectations can shift depending on the severity of the 
individual’s symptoms, the therapeutic relationship with their clinician, and any initial 
treatment side-effects or benefits experienced (Rutherford et al., 2010). Finally, post-
treatment, individuals may experience positive or negative expectations regarding the 
likelihood of staying well. 
Previous research asserts that individuals across all clinical contexts develop 
expectations about whether and how much they will improve based on the information 
provided to them at the beginning of treatment (Rutherford et al., 2010). This notion has 
colossal clinical implications and is postulated as being the primary mechanism of the 
placebo effect (Kirsch, 2017; Rutherford et al., 2010). This has led to the response 
expectancy theory that postulates that subjective and physiological responses can be modified 
by changing expectations (Kirsch, 1997). Response expectancies are considered pertinent 
when recommending and administering treatment for mental health conditions, such as 
depression and anxiety disorders (Kirsch, 1997). For example, previous research indicates 
that information given to individuals about SSRIs can have a greater impact than the 
medication itself (Kirsch, 2017). Similarly, in the context of psychotherapy, the likelihood of 
producing favourable outcomes is dependent on both the health practitioners’ ability to 






promote positive response expectancies and establish a therapeutic alliance and the specific 
treatment (Kirsch, 2017).  
Satisfaction with Treatment 
Another vital influencer of the quality of health care in psychiatric treatment is patient 
satisfaction (Köhler, Unger, Hoffmann, Steinacher, & Fydrich, 2015). Treatment satisfaction 
can be described as an individual’s perception and rating of their experience of the process 
and outcomes of treatment (López-Torres Hidalgo et al., 2016). Patient satisfaction is deemed 
an important component in the care process as it influences consumer behaviour and 
treatment efficacy (Hasler et al., 2004). More specifically, treatment satisfaction is associated 
with treatment compliance, in that a satisfied patient will better engage in psychotherapy 
and/or take their medication as prescribed, thus facilitating optimal therapeutic outcomes 
(López-Torres Hidalgo et al., 2016).  
Patient satisfaction is influenced by a multitude of factors including an individuals’ 
clinical profile, social support, socioeconomic characteristics, expectations and previous 
service experiences (Hasler et al., 2004). Furthermore, patient satisfaction is also dependent 
on the quality of care received, the alliance and support provided by health care practitioners 
and the outcome of care (i.e. perceived improvement as identified by the patient; Hasler et al., 
2004).  
Patient satisfaction is associated with the perception of valuable improvements in two 
specific outcome domains: changes in symptomology and the interpersonal domain (Hasler et 
al., 2004). Research indicates that individuals who experience no therapeutic change are 
consequently dissatisfied with their treatment experience (Hasler et al., 2004). Conversely, 
lower severity of depressive symptoms is associated with higher patient satisfaction (Köhler 
et al., 2015). Similarly, one study reported that individuals with depression who were in their 
first onset of depressive symptoms were more satisfied with treatment compared to 






individuals who had experienced multiple episodes (Köhler et al., 2015). The same study 
found that individuals with psychiatric comorbidities showed reduced satisfaction as the 
number of comorbidities increased (Köhler et al., 2015).  
It is also imperative to consider the type and quality of treatment individuals are 
receiving, although results are sometimes variable. For example, some studies report high 
patient satisfaction during or following inpatient treatment, while others do not (Köhler et al., 
2015). In a study of 648 individuals with comorbid depression and anxiety, individuals who 
received high-quality psychotherapy were more likely to be satisfied with their experience of 
mental health care (Stein et al., 2011). Furthermore, a dose-response relationship was evident, 
wherein greater CBT elements during therapy correlated with higher patient satisfaction with 
care (Stein et al., 2011). The same study reported that the content of sessions corresponded 
more with satisfaction than the number of sessions (Stein et al., 2011). Similar results were 
yielded in a German study, where no significant correlation was found between additional 
sessions of psychotherapy and patient satisfaction (Köhler et al., 2015). 
Interestingly, the delivery of high-quality pharmacotherapy has not been as 
consistently associated with patient satisfaction (Stein et al., 2011). This could potentially be 
explained by the fact that there tends to be less intense clinical care for those taking 
antidepressants, particularly when compared to clinical trials (Sugarman, 2016). In a USA-
based study comprising 84, 514 individuals, only 24% of individuals had a follow-up 
appointment in the first 12 weeks following initiation of antidepressant treatment (Sugarman, 
2016). In addition, research indicates that 73.6% of the USA population who are on 
antidepressants receive their prescription from a GP rather than from a psychiatrist (Mojtabai 
& Olfson, 2008). This finding is particularly important given that research shows that 
individuals who receive their antidepressant medication from a GP are more likely to take 






their medication infrequently or irregularly and to cease their medication within 30 days 
(Mojtabai & Olfson, 2008). 
 Therapeutic alliance and patient-practitioner interaction is another important factor 
that influences patient satisfaction (Köhler et al., 2015). The mere act of accessing a health 
practitioner does not equate to satisfaction with care (Stein et al., 2011). Genuine, personal 
interest and empathy demonstrated by practitioners are significant predictors of patient 
satisfaction (Stein et al., 2011; Swanson, Bastani, Rubenstein, Meredith, & Ford, 2007). 
Communication and shared decision making between an individual and their practitioner are 
also positively associated with increased satisfaction (Swanson et al., 2007). Individuals who 
are given an explanation of their mental health condition and who are actively involved in the 
management and treatment of their condition report being more satisfied with their care than 
those who are not (Swanson et al., 2007). Similarly, individuals who receive patient-centred 
care report higher levels of satisfaction (Rossom et al., 2016). Patient-centred care 
encompasses care that is compassionate, empathetic and responsive to an individuals’ needs 
and preferences (Rossom et al., 2016). Patient-centred care not only improves the patient-
practitioner relationship but also results in the individual feeling more engaged and in control 
of their care (Rossom et al., 2016). Individuals who are more involved in their care not only 
receive guideline-concordant care but also make stronger improvements, all of which 
subsequently contributes to increased patient satisfaction (Winter & Barber, 2013).  
Directions for Future Research  
 The impact, expectations and experience of depression and its subsequent treatments 
are all important concerns, particularly as the prevalence of depression continues to escalate 
globally (WHO, 2017). Recognising and successfully diagnosing depression is deemed 
imperative given that depression is now indisputably considered one of the most prevalent 
disorders and a primary public health concern (Cepoiu et al., 2008). While substantive 






research has focussed on help-seeking in individuals with depression, gaps in knowledge 
remain. Previous studies have recommended that future research on help-seeking behaviours 
among individuals with depression should focus specifically on individual perspectives and 
experiences (Magaard et al., 2017). A better understanding of help-seeking behaviours and 
factors that influence or impede individuals accessing help are crucial, allowing better 
identification of the reasons people fail to seek adequate professional help, and in turn 
improving access to care and patient outcomes (Magaard et al., 2017).  
Research on the impact of patient preferences, expectations and satisfaction of 
treatment for depression has important implications for both clinical practice and future 
research (Gelhorn, Sexton, & Classi, 2011). Given the disparities across the literature 
concerning treatment preference, expectations, satisfaction with and lived experiences of 
pharmacotherapy and psychological treatments for depression, future research should 
endeavour to explore these further. Previous studies that have examined the impact of these 
factors are limited and have predominately used clinical trial data (Gelhorn et al., 2011). 
Future research should be conducted in more naturalistic community settings as opposed to 
clinical trials, as that will allow the opportunity to collect data that encapsulates more “real-
world” depression and its treatment (Gelhorn et al., 2011). 
Previous studies have also reiterated the importance of acknowledging that each 
individuals’ experience of depression and its treatment is unique. Thus, future research 
should examine the potential interaction of the aforementioned areas with factors such as 
patient characteristics, cost constraints, symptom severity and treatment type/setting from the 
perspective of the patient (Winter & Barber, 2013). By gaining an in-depth and sophisticated 
understanding of individuals’ experiences with depression and its treatment, practitioners 
may be better equipped to provide patient-centred care for individuals with depression 






(Hirschfeld, 2012). This, in turn, offers the potential to improve engagement with and 
outcomes of treatment for depression.  
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Objectives: This study aimed to examine lived experiences of individuals seeking help for 
depression, an increasingly pervasive and debilitating disorder globally.   
Methods: Using a qualitative research design, 17 individuals were interviewed about their 
experiences of undertaking treatment for depression, with a focus on treatment preferences, 
expectations and satisfaction with pharmacotherapy or psychotherapy.  
Findings: Two superordinate themes were established from thematic analysis. The first, 
‘Interactions with Health Professionals’, comprised four themes that revealed the importance 
of therapeutic alliance, effective patient-centred care and the adverse effects of negative or 
invalidating experiences. With five themes, the second superordinate theme, ‘Experiences 
with Therapeutic Treatments’, revealed patient preferences, expectations, satisfaction and 
readiness for treatment as overriding influencers.  
Conclusion: Participants described highly individualised experiences of depression, with 
important implications for clinical practice and future research study designs. The findings 
may better equip practitioners to provide effective early treatment and patient-centred care. 
 
  







Major Depressive Disorder (MDD) is a commonly occurring disorder that can 
significantly impact an individuals’ quality of life and often results in diminished and/or 
debilitated functioning (Gerhards et al., 2011; Kessler & Bromet, 2013). While specific 
criteria must be satisfied for a diagnosis of MDD (American Psychiatric Association [APA], 
2013), individuals can experience depressive symptoms including low self-esteem, 
unremitting fatigue, physical malaise, feelings of worthlessness, general loss of interest, self-
harm behaviours and suicide attempts, without satisfying full diagnostic criteria (McCann, 
Lubman, & Clark, 2012; Wang, 2018). Individuals often report associated social 
consequences such as feeling stigmatised, poor relationships, impediments to academic 
learning and/or performance, and unemployment (Wang, 2018).  
Alarmingly, depression is now one of the most prevalent mental health disorders, with 
approximately 300 million people suffering globally (World Health Organisation (WHO), 
2017). Depression is also linked closely to suicide, with approximately 800,000 suicide 
deaths per year, equating to one person every 40 seconds (WHO, 2017). These trends have 
resulted in substantial medical, economic and societal costs (Anderson & Roy, 2013). 
Help-Seeking and Under-Recognition of Depression 
The increased prevalence of depression and its subsequent implications emphasise the 
importance of early detection and treatment. While treatment can reduce much of the burden 
associated with mental illness, many sufferers do not seek professional help (Harris et al., 
2015; Prins, Verhaak, Bensing, & van der Meer, 2008), with the median untreated rate for 
depression more than 50% worldwide (Magaard, Seeralan, Schulz, & Brutt, 2017). Attempts 
to understand patterns of low help-seeking behaviour have consistently found reduced service 
utilisation among males compared to females (BeyondBlue, 2019; Harris et al., 2015). 
Factors that influence help-seeking behaviours include individuals not recognising 






themselves as experiencing psychological difficulties, not believing they will see substantive 
change in their problems, and general stigma (Prins et al., 2008). 
Disturbingly, for those who seek help, successful symptom recognition by non-
psychiatric health professionals remains low (Tiller, 2013). One study reported that fewer 
than half of individuals had their depression recognised by their primary care practitioner, 
even after five years of follow-up (Cepoiu et al., 2008). Under-recognition, under-diagnosis 
and under-treatment can result from inadequate knowledge about diagnostic criteria, 
insufficient insight into various mental health presentations, time pressures, and lack of 
psychosocial orientation (Cepoiu et al., 2008).   
The inability to recognise and diagnose depression can significantly impact outcomes, 
as undiagnosed individuals are often not offered or provided appropriate treatment (Cepoiu et 
al., 2008). Even when diagnosed, many individuals do not commence treatment, do not fully 
participate in it and/or do not complete an adequate treatment course (Saver, Van-Nguyen, 
Keppel, & Doescher, 2007). An individuals’ decision to not initiate or complete treatment 
often results from inadequate health literacy, dissatisfaction with treatments offered (Raue, 
Schulberg, Heo, Klimstra, & Bruce, 2009), or receiving inadequate or insufficient 
information about mental health (Saver et al., 2007). Choosing and recommending the first 
treatment is the most fundamental decision health practitioners face in caring for individuals 
with depression (Dunlop et al., 2017). However, some evidence suggests that practitioners 
advocate for and provide treatments that are not consistent with clinical practice guidelines 
(Jorm, Patten, Brugha, & Mojtabai, 2017). Guidelines recommend that individuals with 
depression should initially be treated with either evidence-based psychotherapy or 
pharmacotherapy, or a combination of the two (Cuijpers et al., 2014; Dunlop et al., 2017). 
 
 






Preferences, Expectations and Satisfaction with Treatment 
Individuals with depression often express well-defined treatment preferences 
(Gelhorn, Sexton, & Classi, 2011), frequently developed from previous treatment exposure or 
experience (Dunlop et al., 2017; Winter & Barber, 2013). An individuals’ beliefs about 
depression and treatment options can vary markedly from those of their health professional 
(Prins et al., 2008). Individuals offered their preferred treatment are more likely to initiate 
and engage in treatment, adhere to treatment regimens, and develop a stronger alliance with 
their practitioner (Dunlop et al., 2017). Clinicians should, therefore, be aware of and when 
appropriate, follow an individuals’ preferences when recommending treatments (Winter & 
Barber, 2013). 
Understanding the role and impact of expectations for pharmacotherapeutic and 
psychotherapeutic treatments is similarly imperative (Rief & Glombiewski, 2017). As a 
“central mechanism of change” (Rief & Glombiewski, 2017, p. 210), expectations can have 
positive or adverse impacts on treatment outcomes (Rutherford, Wager, & Roose, 2010). 
Irrespective of treatment type, expectations about success are the most salient predictor of 
outcomes and can occur at any stage of treatment (Rief & Glombiewski, 2017; Rutherford et 
al., 2010). With significant clinical implications, this is postulated as the primary mechanism 
of the placebo effect (Kirsch, 2017; Rutherford et al., 2010). 
Client satisfaction is another important factor in depression treatment, as it can 
significantly influence consumer behaviour and treatment efficacy (Köhler, Unger, 
Hoffmann, Steinacher, & Fydrich, 2015). A multitude of factors including an individuals’ 
clinical profile, comorbidities, symptom severity and duration, social support, socioeconomic 
characteristics, expectations and previous service experiences are pertinent (Hasler et al., 
2004; Köhler, et al., 2015). Satisfaction is also dependent on the quality of care, the content 
(rather than number) of sessions and outcomes of care (Hasler et al., 2004; Köhler et al., 






2015; Stein et al., 2011). Interestingly, the delivery of high-quality pharmacotherapy has not 
been as consistently associated with satisfaction (Stein et al., 2011), possibly because there 
tends to be less intense clinical care (Sugarman, 2016).  
Therapeutic alliance and authentic patient-practitioner interaction are other important 
influencers of client satisfaction (Köhler et al., 2015; Stein et al., 2011; Swanson, Bastani, 
Rubenstein, Meredith, & Ford, 2007). Individuals who receive patient-centred care report 
greater satisfaction, which, in turn, improves the client-practitioner relationship and leaves 
the client feeling more engaged and in control of their care (Rossom et al., 2016). 
The Current Study 
Given the continued global escalation in depression (WHO, 2017), its impact and 
clients’ experience of treatment are of paramount concern. While a substantial amount of 
research has focussed on help-seeking, gaps in the literature remain. Greater focus on 
individual perspectives and experiences is required (Magaard et al., 2017). A better 
understanding of help-seeking behaviours and factors influencing and/or impeding access to 
care are crucial to improving access to treatment and client outcomes (Magaard et al., 2017).  
Research regarding client preferences, expectations and satisfaction with treatment 
has important implications for clinical practice and future research (Gelhorn et al., 2011). 
Given disparities across the literature in regard to treatment preferences, expectations, 
satisfaction, and lived experiences of pharmacological and psychological treatments, further 
investigation is required. Research conducted in more naturalistic community settings rather 
than clinical trials allows the opportunity to collect data on “real-world” experiences of 
depression (Gelhorn et al., 2011). While each individual’s experience of depression is unique, 
research documenting this variability remains limited. There are also few qualitative studies, 
even though these provide rich sources of data (McCann et al., 2012). A greater 
understanding of influencing factors such as client characteristics, symptom severity, and 






treatment type/setting and cost, from the perspective of the individual, is also required 
(Winter & Barber, 2013). By gaining an in-depth understanding of individuals’ lived 
experience with depression and its treatment, practitioners may be better equipped to provide 
early intervention and patient-centred care (Hirschfeld, 2012). The current study, therefore, 
aimed to use a qualitative approach to examine individuals’ lived experience of seeking help 
for depression, including exploring treatment preferences, expectations and satisfaction with 
treatment.   
Method  
Participants 
Semi-structured interviews were completed with 17 South Australian individuals who 
self-identified as having been diagnosed with depression or MDD. Five men and 12 women 
aged between 18 and 39 years (M = 23.7 years, SD = 6.05) participated. At the time of their 
interview, using the Depression Anxiety and Stress Scale (DASS-21), five participants’ 
depression symptoms were within the normal range. Of the others, three were in mild, three 
in moderate, two in severe, and four in the extremely severe ranges, respectively. Table 1 
provides a summary of participant characteristics.  
Eligibility criteria for participation included being at least 18 years of age, fluent in 
English, having experienced self-identified or health professional-diagnosed depression and 
having undertaken treatment (pharmacotherapy or psychotherapy) for depression. Efforts 
were initially made to screen and exclude individuals who had comorbid mental health 
disorders. However, during interviews, some participants disclosed previously unidentified 











Summary of Participant Characteristics 
 Name* Age Gender Ethnicity Relationship* Living* Education* Studying* Employed* 
Yuri  21 M Afghan Single Family Year 12 Yes Yes – P/T 
Emma  20 F Australian Single Friends Year 12 Yes Yes – P/T 
Adam   31 M Australian Single Alone TAFE No Yes – P/T 
Kate 20 F European Single Family Year 12 Yes No 
Natalie  39 F Asian Married Partner Post Grad Yes Yes – F/T 
Lucy 28 F American Single Alone Und Grad Yes Yes – P/T 
Gemma  19 F European Single Alone Year 10 Yes No  
Alice 21 F Australian Single Family Year 12 Yes Yes – P/T 
Sarah  19 F Australian Relationship Alone Year 12 No  Yes – P/T 
Matt 21 M European Single Family Year 12 Yes No 
Mia 32 F Australian Relationship Family Und Grad Yes Yes – P/T 
Claire  19 F Australian Single Family Year 12 Yes Yes – P/T 






Kim 29 F Australian Married Partner Und Grad Yes Yes – P/T 
Colin 18 M Australian Single Family Year 12 Yes No 
Rachel 23 F Australian Relationship Partner Und Grad No Yes – P/T 
Sally 18 F European Single Family Year 12 Yes No 
David  25 M Australian Relationship Partner Year 10 Yes No 
*Note: Participant names are pseudonyms; Relationship = Current relationship status; Living = Current living arrangements; Education = Highest level of educational 
achievement; Studying = Currently studying, Employment: F/T = Full-time employment and P/T = Part-time employment.    







 This research was approved by the University of Adelaide Human Research Ethics 
Committee (H-2018-250). Information and flyers were submitted to local psychology and 
medical practices, such as the University of Adelaide’s Counselling Service and the  
University Health Practice. Recruitment also occurred via a second flyer posted to online 
forums and social media platforms, and snowball sampling. Potential participants were 
invited to contact the researcher to express their interest. Written consent was obtained from 
all participants before participation.  
Participants also completed a brief questionnaire, including demographic information, 
before their interview. All participants also completed the DASS-21 to determine the severity 
of their depression at the time of interview (See Table 2). 
Semi-structured interviews were employed. Interview questions were developed 
based on previous studies across relevant literature (Bosman et al., 2016; Buus, Johannessen, 
& Stage, 2012; Jaffray, Cardy, Reid, & Cameron, 2014; Saver et al., 2007). Example 
questions included: “Can you describe what depression has been like for you”, and “How 
satisfied would you say you are with medication [and/or psychotherapy] as a treatment option 
for depression?”. Following inductive reflexive thematic analysis research methods (Braun & 
Clarke, 2006; 2013), two pilot interviews were conducted to assess the appropriateness of the 
interview schedule. Minor adjustments were made to the order of questions; these pilot 
interviews were included in the data set. 
Fifteen interviews were conducted face-to-face, and two interviews were via 
telephone. Interviews ranged between 27 and 85 minutes, with an average length of 58.3 
minutes. Data saturation usually occurs at between eight to twelve interviews (Guest, Bunce, 
& Johnson, 2006). However, due to the diverse array of participants and their experiences, 
data collection continued for 16 interviews. Following the completion of data collection, an 






additional individual expressed interest in participating. Due to the sensitive nature of the 
research topic, the researchers wanted to allow all interested individuals to share their 
experience; therefore, this individual was interviewed and included in the data set. Following 
the completion of the seventeenth interview, strong re-emerging themes were observed.  
However, given the diversity of participants and their experiences, it is difficult to know if 
total saturation had been reached. All interviews were audio-recorded with participants’ 
permission and transcribed verbatim using an orthographic method (Braun & Clark, 2006; 
2013). Confidentiality and anonymity were maintained by allocating each participant a 
pseudonym. All names and any identifying features were removed from the transcripts.  
  







Summary of Participant Psychological History  
    DASS-21* 
Name* Diagnoses* Status* Treatment Undertaken Depression Anxiety Stress 
Yuri  Depression Ongoing   Therapy and medication  Moderate (18) Moderate (14) Severe (26) 
Emma  Depression; Anxiety Resolved Therapy  Normal (2) Normal (2) Normal (8) 
Adam   Depression; Anxiety; 
ADHD  
Ongoing  Therapy and medication Moderate (18) Normal (4) Mild (16) 
Kate Depression  Ongoing  Therapy and medication Normal (6) Moderate (10) Moderate (22) 
Natalie  Depression Ongoing Therapy and medication Normal (2) Normal (2) Normal (10) 
Lucy Depression Ongoing Therapy and medication Mild (12) Normal (6) Normal (14) 
Gemma  Depression  Ongoing Therapy and medication Severe (22) Normal (4) Normal (6) 
Alice Depression; Anxiety Ongoing  Therapy and medication Extremely Severe (34) Extremely Severe (26) Severe (26) 
Sarah  Depression; Anxiety  Ongoing Therapy and medication  Mild (10) Severe (18) Mild (18) 
Matt Depression; ASD Ongoing Therapy  Extremely Severe (34) Moderate (12) Moderate (24) 






 *Note: Participant names are pseudonyms; ADHD = Attention Deficit Hyperactive Disorder; AN = Anorexia Nervosa; ASD: Autism Spectrum Disorder; DASS-21 = 
Depression Anxiety Stress Scales-21; (no.) = The raw scores of each subscale of the DASS-21; Diagnoses = Diagnosis/diagnoses participants had received; Status = If 




Mia Depression; Anxiety Ongoing Therapy and Medication  Normal (6) Extremely Severe (20) Normal (12) 
Claire  Depression  Ongoing  Therapy and Medication Mild (12) Moderate (14) Normal (12) 
Kim Depression; Anxiety Ongoing  Therapy and Medication Severe (22) Moderate (12) Moderate (22) 
Colin Depression Ongoing Therapy and medication Extremely Severe (40) Moderate (14) Mild (16) 
Rachel Depression; Anxiety Ongoing  Therapy and Medication Normal (4) Normal (6) Normal (12) 
Sally Depression; AN Ongoing  Therapy and Medication  Extremely Severe (32) Extremely Severe (22) Normal (8) 
David  Depression Ongoing Therapy and Medication  Moderate (16) Normal (6) Normal (14) 






 Meticulous qualitative research methodology was followed to enhance 
methodological rigour (Tracy, 2010). An audit trail was maintained to facilitate data analysis, 
continuously reflect on the quality of the interview process and subsequently inform any 
potential modifications to future interviews. The audit trail also included records of all 
interactions with participants and attempted contact made with various organisations during 
recruitment. Member reflections were sought, with all participants provided with the 
opportunity to review their transcripts (Tracy, 2010). A total of 12 participants responded, 
confirming their transcript; no changes were made to any transcripts.  
 Self-reflexivity, the process of engaging in an honest and transparent self-awareness 
process, is considered a crucial component of qualitative research (Tracy, 2010). Moreover, 
self-reflexivity assists in identifying and minimising the effect of researcher bias (Tracy, 
2010). The primary researcher has not experienced depression, although concurrently 
practices as a provisional psychologist. Some participants were aware of the researcher’s 
role, and while any questions concerning this were deferred until after the interview, this may 
have influenced how participants interacted with the researcher. Furthermore, awareness of 
the researcher’s role may have led to assumptions that certain experiences were understood 
by the researcher and thus did not require further explanation by the participant. However, 
during the interviews, several participants stated that they were sharing their experiences, as 
they hoped that by doing so, they may help others who experience depression.   
Data Analysis 
 Thematic analysis was used to examine and synthesise the data from a realist 
ontological position (Braun & Clarke, 2006; 2013). This position postulates that reality is 
independent from human knowledge, interpretation and understanding (Braun & Clarke, 
2006; 2013). Each interview was therefore analysed and interpreted as a direct reflection of 
lived experiences. Braun and Clarke (2006; 2013) describe six main steps involved in 






undertaking thematic analysis. The initial step comprised immersion and subsequent 
familiarisation with the data which was achieved via transcription, continuous reading, and 
noting of preliminary concepts and ideas. Secondly, initial codes were generated by 
categorising interesting features of the data which captured the research aim. The third step 
involved collating the initial codes into prospective emergent themes and sub-themes. During 
the fourth step, themes were reviewed and reconsidered with respect to the raw data, initially 
established codes and applicability to the research aim. Fifth, themes that best captured and 
epitomised the data were refined, defined and named, resulting in the development of two 
superordinate themes and nine themes. Finally, compelling extracts were selected and used to 
represent each theme.   
 An inductive approach was used to examine the data, whereby numerous themes were 
identified. The primary researcher completed the initial coding. However, to ensure 
consistency and trustworthiness of the chosen codes and themes, the research supervisor 
concurrently coded four transcripts. These four transcripts, codes and initial themes were then 
discussed collaboratively. Following discussion and refinement, the remaining transcripts 
were revisited, and a final thematic structure was established and agreed upon by both 
researchers.  
  







Two superordinate themes, Interactions with Health Professionals and Experiences 
with Therapeutic Treatments, were identified and are described below. 
Superordinate Theme 1: Interactions with Health Professionals  
Within this superordinate theme, four themes were identified, “The importance of 
therapeutic alliance”, “Dismissive and invalidating experiences are detrimental to 
satisfaction”, “Health professionals who exert undue pressure are demonstrating 
inappropriate practice”, and “Effective patient-centred care”. 
Theme 1: The importance of therapeutic alliance  
Therapeutic alliance emerged as a dominant theme, particularly in relation to 
participants experience, and the perceived importance of therapeutic alliance. However, both 
of these parameters also showed variation across participants. Some participants reported 
strong therapeutic relationships with their health professionals which positively influenced 
their experience. More specifically, participants often referred to their health practitioners as 
“emotionally supportive” (Emma). For example: 
 “I found it really helpful and just that like – that relationship with the person 
and, yeah, just being so safe and accepting and, you know when I first started 
going I didn’t have any sort of positive male role models or relationships in 
my life so that was really empowering as well, to be in that safe space.” – 
Rachel   
Many participants indicated a positive therapeutic alliance to be extremely important. For 
some, their health professional was the only conduit to express their current circumstances. 
This is demonstrated by one example:  
“Of course it’s comfortable. I feel safe. I guess since I don’t talk with many 
people, I don’t talk to at all with anyone, she kind of fills a – oh, I don’t want 






to say role. We want to be with others. You know, I guess she’s the only line I 
have.” – Yuri   
Conversely, others described less positive relationships, where they did not feel comfortable 
with their practitioner, and this subsequently impacted on their experience. In some instances, 
it also affected treatment outcomes as noted by one participant:  
“I guess part of it was I was bowing to the authority. It was I’ll go with what 
she says because she’s the trained professional but yeah, I probably should’ve 
spoken up and said ‘I don’t think this is working.” – Adam   
Most participants commented on the importance of not settling for just any health 
professional. They reiterated the criticality of finding a health professional that they felt 
comfortable with and who fitted their needs. For example:  
“I think you just try to find a counsellor that you’re comfortable with and not 
just go with anyone. Like if you’re not satisfied with one of the counsellors just 
try another one and try another one until you find someone who you’re 
comfortable with.” – Natalie   
Many participants reflected that their experience with their health professional tarnished their 
perceptions, experience of and/or engagement with therapy. More specifically, participants 
described how their health professional deterred them from continuing therapy. For example:  
“I went to a lot of sessions and even after that it was just kind of like I still 
didn’t see this therapist as someone I could openly talk about my life so I think 
part of me wishes that maybe I’d gone on and maybe tried to find a different 
therapist. I think if you can find the right person to kind of click with and the 
right person to kind of talk to I think it can help.” - Claire  
Some participants also noted differences in therapeutic relationships dependent on the 
discipline of the health professional:  






“I don’t know why it felt very comfortable talking to the psychiatrist and when 
I went to the psychologist I didn’t feel that comfortable. I have no idea why. 
Maybe its because you have to have like a personal connection with... like you 
have to like the person and my first sessions I didn’t really connect with her.” 
– Lucy   
Theme 2: Dismissive and invalidating experiences are detrimental to satisfaction  
Participants described instances where they felt their health professional was not 
listening and/or did not take them seriously. This attitude not only affected their satisfaction 
with treatment but also their propensity to seek help. While participants often acknowledged 
that their health professional was ‘the expert’, they also reflected that they had hoped their 
health professional had taken them seriously. Many participants reported incidents where 
they were told “you don’t know what you are talking about” (David) or when their concerns 
were dismissed, and they were advised to “get over it” (Natalie). This is illustrated by Sarah 
and Yuri:  
“It kind of just made me feel like they would be very blasé about stuff I told 
them that was very serious to me but I felt wouldn’t be serious to them.” – 
Sarah  
“Sometimes it felt like she was cutting through the fat and getting straight to it 
but sometimes it [she] felt she was deaf or something.” – Yuri   
Several participants expressed concern that their health professional did not acknowledge the 
severity of their symptoms and/or experiences. For example:  
“Then when things were really bad I saw a doctor and I was thinking that, you 
know, I really wanted to go on medication because I was just feeling out of 
control. She didn’t want to give me any medication and suggested that I do 






some yoga and I was like ‘things are a little bit worse than that right now’.” – 
Rachel  
Furthermore, subsequent treatment modalities suggested by health professionals sometimes 
resulted in participants feeling frustrated, invalidated and dissatisfied with the current health 
services being provided:  
“I was really frustrated at the time with psychiatrists, I still have that 
frustration today because I have been in hospital two times and every time I 
have talked to a psychiatrist they have been incredibly dismissive and 
sometimes narcissistic and it’s frustrating, and I just feel like I wasn’t getting 
the help that I needed.” – David.  
Many participants admitted that due to previous invalidating and dismissive experiences, they 
subsequently ceased engagement with their health professional and/or treatment and remain 
reluctant to engage in mental health services. This is highlighted below:  
“I didn’t think they’d understand. Because of this experience I had with 
doctors I thought I would just be disregarded because of my age. I felt I’ve 
been disregarded a lot for health issues, apart from this, because of my age, 
because people don’t believe me.” – Sarah  
Theme 3: Health professionals who exert undue pressure are demonstrating inappropriate 
practice 
While many participants described positive experiences with their health 
professionals, some recounted instances where their health professional exerted undue 
pressure. More specifically, participants recounted instances where they had expressed 
concerns to their health professional regarding their treatment that were subsequently 
ignored:  






“Once I realised that the level that it’s set at was not a particularly happy 
one, like I was kind of keen to try something different, but he was saying ‘No. 
We’ll keep trying on this one, see how it goes.” – Adam   
Moreover, many participants described a desire for their health professional to respect their 
opinions, input and decisions more. For example: 
“She said ‘I very strongly think that you should tell your mother because then 
she’ll be able to help you if something, you know, in regards to that (sexual 
abuse) comes up’ and I said ‘I don’t really feel comfortable doing that’ and 
she said ‘I think you really should’. Like she really pushed it.” – Kate  
Participants also reflected concern in instances where their health professional had breached 
confidentiality, and stated that this had subsequently impacted and ruptured rapport with the 
therapist:    
“Well there was a bit of a wobble when she brought my mum in and I felt she 
disclosed things to my mum that I wasn’t ready for her to share with her and I 
hadn’t intended to share with her.” - Gemma 
In the context of psychotherapy, many participants expressed concern about the quality of 
therapy and/or the approach taken. More specifically, one participant described sessions that 
ultimately ended up “being a coffee date more than a therapy session” (Sarah). Another 
participant stated:  
 “She would kind of touch me that would make me feel <gesture>. I would 
hate it, like she would touch my hand and do things like that. I have no idea 
what that is.” – Lucy.  
Some participants described pressure from their health professional to cease therapy when 
they were not necessarily ready to do so. For example:  






“Things would get better for me a little bit and then they would say ‘you are 
feeling a bit better so we are going to stop the treatment, stop the counselling’ 
and I would go off and things would get worse again.” – David  
Conversely, other participants reported instances where their health professional 
exerted pressure on them to remain in therapy, as illustrated below: 
“I remember he tried a lot to keep going, keep going, just kept going, because 
it was kind of like the moment of – he was very persistent with the counselling 
but you could tell that I didn’t want to be there and it was kind of just this 
awful thing where he kept going and my parents kept kind of making me go.” 
– Claire   
Theme 4: Effective patient-centred care  
Many participants described receiving compassionate, empathetic care, responsive to 
their specific needs and/or preferences. Participants reported experiences where their health 
professional comprehensively explained various treatment options before collaboratively 
reaching a decision. Other participants reported that their health professional advocated for 
them to lead their own care. For example:  
“It was more my decision kind of thing. He was always open about it. He 
never really recommended one over the other. He was kind of just very open 
with the idea and he always just kind of left it up to me so at the end of the day 
it was my choice to kind of be able to take the time and to think about what I 
wanted to do before I went further and went back and told him, he would 
discuss with me where we’d go from there kind of thing.” – Claire  
Conversely, other participants described being uninvolved in the decision-making process 
about their treatment options. Some participants reported that they preferred being directed 






by their health professional, others reflected they wished their health professional had 
demonstrated a more collaborative approach:  
“Like kind of me but also it wasn’t an active decision. I wasn’t like 
empowered to make it, I just kind of took the medication and went to the 
psychologist and hoped for the best, kind of. Yeah I think it didn’t feel like – it 
felt like a passive sort of decision, just following what everyone, the doctor 
and the psych were telling me was probably a good plan. Yeah I definitely 
wasn’t like empowered or didn’t feel like I was in charge, but I was just kind 
of getting by and doing what I had to.” – Rachel   
As noted by Natalie, the apparent lack of patient-centred care demonstrated by some health 
professionals often resulted in patient dissatisfaction: 
“I don’t think they actually care. Like my GP, she spend too much time on – 
you know, she spend half an hour with me. The psychiatrist just ‘tick, tick, tick, 
tick’ didn’t even look up, and just – yeah I don’t think they care. No. No, I 
didn’t really have much choice at all.” – Natalie  
Superordinate Theme 2: Experiences with Therapeutic Treatments  
Within this superordinate theme, five themes were identified, “Patient preferences 
make all the difference”, “The reality of patients’ expectations”, “Readiness influences 
uptake and satisfaction”, “Factors influencing and/or impeding therapeutic success”, and 
“Satisfaction with treatment”.  
Theme 1: Patient preferences make all the difference  
 Participants indicated varying preferences towards pharmacotherapy and 
psychotherapy. Preferences were based on a myriad of factors including prior experience, 
previous treatment and input from friends or family members. For example:  






“Of course the opinion of my family counted a lot so my father and my mother 
not being very encouraging about it also made me not want to go so I think 
that’s the reason. I didn’t really want to be active, I just wanted to take my 
medication and make it go, make the symptoms go away.” – Lucy  
Participants offered their preferred treatment were more likely to initiate and engage in 
treatment, adhere to treatment regimens, and develop a stronger alliance with their 
practitioner, as exemplified below: 
“I sort of took matters into my own hands and I said to my doctor I want to go and 
see a psychiatrist, I did and I said to her, “look I am here today and I just want 
Phenelzine, because this is what I think I have”. And she was like “fair enough you 
have been on a bunch of different ones”, and she gave it to me sort of thing. And it 
worked really well.” - David 
Similarly, when participants undertook a non-preferred treatment, it often resulted in them 
feeling dissatisfied and discouraged from remaining in treatment. This is emphasised in the 
extract below:  
“I don’t think therapy was the right answer personally for me because I was 
always very much – I didn’t want to talk about things in my life to a complete 
stranger. I didn’t think it was ever something that I wanted to do” - Claire 
While some participants expressed uncertainty and ambivalence towards medication, many 
indicated a preference for medication as they perceived it as an “easy option” and a “quick 
fix”. Several participants explained that they were seeking short-term gains and thus were 
predominately interested in commencing pharmacotherapy: 
“I was a bit biased because I had my mind set of getting medication to get me 
through my year 12 exams because this was a time where I didn’t want to be 
looking at long term; I wanted short term solutions.” – Sarah 






Some participants described instances where their preferences and right to preferences were 
taken away from them. This predominately occurred for those considered minors at the time 
they undertook treatment or those who were forcibly admitted to hospital. For example:  
“I don’t think I had one. I think at the time because it was never – I think I 
wished it would’ve been my choice to go and seek help because it was always 
just my parents that kind of played that role, I guess, and what I was doing 
and where I was going.” – Claire   
In these instances, participants highlighted that they “didn’t really have any choice” and were 
“forced” (Natalie) into undertaking various treatments. As noted by Alice below, such 
instances corresponded with strong dissatisfaction with the treatment experience:  
“I was really scared and I just wanted to go home. So when they told me that I 
didn’t have a choice in going to see the therapist, yeah it made me really, 
really angry.” – Alice  
Finally, many participants discussed preferences about psychologist characteristics. 
Preferences were discussed in terms of clinician gender, age, experience and speciality. These 
preferences also subsequently impacted therapeutic alliance and engagement in therapy. For 
example:  
“I just liked the idea of talking to a girl than a boy I think because I was 
younger and just found it more comfortable and I would have found the girl 
easier to talk to.” – Emma  
Due the specificity of preferences, many participants described and advocated for the 
importance of conducting independent research into potential health professionals before 
engaging in therapy.  
 
 






Theme 2: The reality of patients’ expectations  
 Participants recounted a diverse range of expectations concerning treatments. Many 
participants reflected that they did not have expectations before treatment. They described not 
possessing expectations because they were adamant that nothing could change the way they 
were feeling. For example: 
“Thinking back I think I was too depressed to even think about a better future, 
better alternative. Everything looked bad in general.” – Yuri  
In contrast, other participants described having positive expectations before undertaking 
either psychotherapy or pharmacotherapy because they believed that they could not feel any 
worse than they already were: 
“I thought I couldn’t be any worse than like I was already so I kind of 
changed my perspective, I guess. I was pretty hopeful. Maybe not like certain 
but I was hopeful.” – Kate  
Furthermore, a lack of understanding of what treatments entailed appeared to correspond with 
minimal expectations. 
“Yeah I mean I wasn’t really sure what to expect. We sort of have this idea of 
what therapy is, you know lying on the couch and what not but yeah I guess I 
didn’t really have any expectations going in.” – Alice  
Many participants explained they could not understand how talking to someone “about it was 
going to make it go away” (Emma), and thus, initially perceived therapy as a “waste of time” 
(Sarah). Moreover, numerous participant responses indicated that their confidence in, and 
expectations of treatments were often dictated and determined by their prior knowledge and 
understanding. For example:  






“Wouldn’t say I was confident at all. I don’t think I knew enough. I didn’t 
know if people recovered. I didn’t know if you lived with it forever, or if it 
goes away, gets better or worse.” – Rachel   
Not surprisingly, participants expressed minimal expectations when they had previous, 
unsuccessful experiences with treatment: 
“I didn’t really expect anything out of it because I had a bad experience with 
a counsellor before I went to the hospital so I just thought ‘this is useless and 
a waste of my time’.” – Natalie  
Similarly, many participants described initially feeling confident and having high 
expectations about their treatment. However, this optimism and positivity often waned as the 
duration of treatment increased, while their perceived positive outcomes decreased. For 
example: 
“Going to see the psych and talking about my feelings and the medication, 
none of it really felt like it was making me feel better about stuff, it’s just the 
medication I hate it because of how flat it made my feelings go and, you know, 
maybe if I had more sessions with the psych or a [slightly different approach] 
then it might’ve felt better but I just – I felt so down.” – Adam  
Many participants reflected that they expected that treatment would remove their depression:  
“I didn’t really know how long it would take to resolve and it has – over time 
I’ve found that it’s something I’m just always going to have to live with and 
that’s not what I originally expected. I didn’t expect that I would spend the 
next decade with coming and going of major mental health problems.” - Kim 
More specifically, many participants described having high expectations about the impact of 
antidepressants due to pre-conceived ideas. However, many participants described feeling ‘let 
down’ by the reality of their experience with medication: 






“I expected the medication to solve everything, which was unrealistic of me 
but I expected to take the medication and turn back into the person I was 
before I started feeling depressed. So it didn’t meet my expectations at all.” –
Sarah  
Moreover, some participants reflected that despite their expectations, antidepressants 
were not a panacea and that their recovery was longer and harder than they 
anticipated:  
“I wouldn’t say so because I kind of expected more from it. I expected a real 
boost, a real kind of perk up, and I expected to take the medication and be 
able to function but there’s actually like 80 percent more hard work that you 
need to do. I think I went into it thinking that it would fix all the problems but 
it really doesn’t, it’s just a kind of a little booster, so that was really different 
to my expectations.” – Rachel  
Similarly, participants described never anticipating that treatment could make them feel 
worse. Many participants reflected how they often found psychotherapy challenging and 
draining; however, reiterated that it was worth it in the end:  
“I never expected that, that I would sometimes feel worse and she’s like ‘it 
might feel worse initially but it’ll end up being better. It’s because you’re 
probably just getting a lot of, you know, home truths and lightbulb moments 
and things like that but it will become easier’ but I did not expect it to be like 
that, so, yeah, draining and challenging but also probably that all worked out 
to be really beneficial.” - Mia 
Theme 3: Readiness influences uptake and satisfaction  
 Readiness to undertake treatment was another emerging theme described variously by 
participants. For example, some people described readiness in terms of motivation, 






willingness to accept they had a problem and therefore needed treatment or wanting to 
initially manage self-sufficiently. For example: 
“I felt that it was something that I could just get over without them. It was 
something that I could just move on from in my life, that I needed to change 
my lifestyle and once I could do that, things would improve and after realising 
that wasn’t working… I said screw it.” - David 
Many participants reportedly commenced treatment despite not being “ready” and 
subsequently had negative experiences, resulting in dissatisfaction:  
“I don’t like admitting that I had a problem, that I needed help. It frustrated 
me because I didn’t want to admit that there was a problem so yeah I just 
hated it.” – Alice  
In contrast, other participants discussed readiness from a more positive perspective:  
“Like I was kind of ready to do whatever it took, so was pretty sure that you, it 
would work, well, I was hoping it would.” – Matt  
Furthermore, some participants, irrespective of previous experience, indicated that their 
readiness influenced their willingness to undertake treatment:  
“I haven’t really had a lot of good experiences with therapy but I was like 
very willing to like participate in that.” – Kate  
Participants often reflected that they engaged in therapy because of their friends and/or 
family members. However, participants also indicated that they would advise others not to 
undertake treatment simply because someone else recommended them to:   
“I think that was the issue, that it was never like I was walking into this room 
and being like ‘I am willing to tell you about my life’ it was just ‘I am here 
because I am forced to be here’ so personally for me it wasn’t something that 
worked.” – Claire  






Theme 4: Factors influencing and/or impeding therapeutic success 
 Given that each participant had highly individualised experiences of depression, the 
factors that influenced or impeded therapeutic success were also highly varied. Many 
participants reported extremely inconsistent experiences and satisfaction relating to 
antidepressant use. For example: 
 “It was getting worse, especially when I was on Escitalopram. I remember 
feeling like I was probably at my lowest point on Escitalopram when I tried to 
commit suicide at the time. But the overall arching picture is that it didn’t help 
with the depression.” – David 
While some participants reported positive experiences with antidepressants, many reported 
concerns and/or factors that impeded satisfaction and success with medication. For example, 
all participants noted complicating and at times, debilitating side-effects of antidepressant 
medication. Participants reported that the side-effects varied depending on the medication 
type. Side-effects included increased suicidal ideation, changes to libido, nausea, physical 
pain, weight gain, memory difficulties, lethargy, increased irritability and/or anger, and 
suppressed emotions or emotional responses such as crying. For example, Sarah noted: 
“I felt it was harder to feel emotion. I felt kind of numb a lot of the time. I also 
found that I couldn’t cry, which was strange. Like stuff that would normally 
make me cry or whatever, I just kind of didn’t have that access to let emotion 
out. I kind of felt very trapped in my body, which was part of the reason why I 
took myself off medication.” – Sarah   
Many participants described antidepressants as making them feel “numb” and that they were 
not themselves. Participants expressed how before medication they were ‘depressed’ but that 
they were still able to have moments of happiness and euphoria. Participants reported 






dissatisfaction with antidepressants because those moments were taken away. Claire provided 
an illustrative example of this phenomenon: 
“It was like third person perspective again but it was almost like a different 
filter, like someone had kind of taken away that dark filter and then suddenly 
put on like this motivational music for my life and I was like ‘I don’t want it’. I 
wanted an experience where it was still going to be me at the end of the day 
and even with everything, how bad it was, like I could still experience some 
moments and the better moments as myself and look back at them later on and 
be like ‘I felt present. I felt there’ rather than like that third person being like 
‘I remember that, but that wasn’t me that was there, that was somebody 
completely different’.” - Claire 
Participants also explained they needed to take additional medication to counteract anti-
depressant side-effects:  
“I had lots of different types of medication. Some were for the side-effects of 
the previous one so it was kind of messy and I didn’t really have a say on how 
much I wanted to do it and for how long and if I wanted to do it.” - Lucy 
Many participants expressed uncertainty around the duration they would remain on 
medication. Moreover, they conveyed concern around the potential long-term impacts of 
remaining on antidepressant medication indefinitely. For example:   
“Yeah I feel like it boosts me up a little but potentially not enough to warrant 
taking them forever.” – Rachel  
Despite this, participants noted that the ease and accessibility of accessing antidepressants 
was a positive factor. Participants who undertook pharmacotherapy advised that they were 
able to access medication that day or within the following few days. In contrast, participants 






described that the waitlists and challenges associated with accessing a psychologist were a 
significant barrier and deterrent to therapeutic success:  
“If you can just like ease up on the waiting time because if somebody needs to 
see a psychologist it needs to be now, like they’re not going to be like ‘oh I 
think I’m going to be really bad in a few days.” - Mia 
Participants had engaged in various forms of therapy including Cognitive Behavioural 
Therapy, Acceptance and Commitment Therapy, Dialectical Behavioural Therapy, 
mindfulness, chair work and trauma-based therapy. Participants reflected that every 
psychologist is very different in their approach to therapy: 
“There is no standard to the treatment, if I would say anything. It is very much 
the own philosophy of that therapist and how they treat depression. I wouldn’t 
say it was outside the bounds of their professional training but there is a 
difference between them all.” – David    
Participants reflected that irrespective of the therapy modality, having a good psychologist 
was imperative to treatment satisfaction and outcomes. For example: 
“Yeah, its been really good and I don’t think I’ll ever stop going because I 
find it so helpful and if my psychologist moves away I’ll be screwed.” – Mia 
Another factor that participants identified as influential to their therapeutic success was that 
treatment helped them to develop insight into themselves and their experience and allowed 
them to consider things from different perspectives: 
“Maybe helped me to understand why I was thinking certain things because 
sometimes you don’t necessarily analyse why I do things and why I think a 
certain way, you know. Made me kind of understand maybe a bit more about 
myself.” – Kate  






Treatment also helped some participants to notice that gains can be slow, or small, but that 
they are all beneficial and should be recognised:  
“Recognising that small steps are still steps, they’re still improvements. Being 
able to tell myself that its not my fault, that it is actually – you know, it’s 
depression.” – Adam  
Theme 5: Satisfaction with treatment  
Many participants initiated discussion about their satisfaction with treatment. Some 
participants positively endorsed their experience, outcomes and satisfaction with 
psychotherapy. For example:  
“Well, I don’t think I would be recovered without it and I don’t think I would 
be well without it and I’m not even sure if I would be alive because I was 
struggling so much, so probably a lot. I think it’s been like the core of my 
recovery. It’s been my biggest tool and where I’ve probably learnt the most. 
It’s like the foundation, almost, of my recovery.” – Mia  
Similarly, other participants spoke positively about their experience, outcomes and 
satisfaction with pharmacotherapy:  
Phenelzine which is the one I am on now, that has completely changed my life. 
That one has all but cured my depression, oh, I wouldn’t say cured it, that’s a 
bit of a stretch but it has helped significantly. I have never had anything like it, 
it was just insane how much it changed things for me.” – David 
However, many participants reported disappointment with their treatment. For example, 
participants described that they had expected better outcomes which subsequently resulted in 
reduced satisfaction:  
“I thought that it would help a lot better than it has.” – Sally   






“It would be nice if things were done a lot quicker rather than suffering for 
however long it is.” – Colin  
Despite their experiences, many participants indicated that they would still recommend 
treatment to others:  
“I would because like I’ve heard good things about it, not necessarily because 
it worked well for me but that it kind of usually works well for a lot of people. 
I’d still recommend it.” – Sally  
In contrast, many participants previous experience and satisfaction with treatment 
subsequently influenced the likelihood of them engaging in treatment again:   
 “It’s a bit difficult now because I don’t really want to go back on medication 
because I hated it. I don’t really want to be going back and seeing a 
psychologist because I hated the sessions I was doing that. I can recognise the 
signs of depression coming back and I really don’t want them to because if it 
gets much worse I’m going to have to try again.” – Adam  
Similarly, due to dissatisfaction with their treatment, many participants reported ambivalence 
in recommending treatment to others:   
 “I don’t think I’d recommend it but I also wouldn’t say ‘don’t bother’.” – 
Colin  
Discussion 
MDD is the most common and debilitating psychiatric disorder globally, yet it is 
often underdiagnosed and undertreated (Kraus, Kadriu, Lanzenberger, Zarate, & Kasper, 
2019). This is despite ongoing efforts to increase knowledge and skills for health 
professionals. It is therefore imperative that there is a greater focus on understanding an 
individual’s preferences, expectations, experiences and satisfaction with pharmacotherapy or 
psychotherapy as treatments for depression. Using thematic analysis of qualitative interviews, 






this study explored treatment preferences, expectations and satisfaction to examine the lived 
experiences of individuals seeking help for depression.  
Two superordinate themes were identified. The first, ‘Interactions with Health 
Professionals’ comprised four themes that revealed the importance of therapeutic alliance, 
effective patient-centred care and the adverse effects of negative and/or invalidating 
experiences. Participants described interactions with health professionals as pertinent to their 
experience of accessing and engaging in treatment. While some reported strong, positive 
relationships with their health professionals, others described less positive relationships. 
More specifically, there were examples of dismissive and/or invalidating experiences. While 
these instances were often experienced differently across individuals (i.e. feeling judged, not 
listened to or not taken seriously), they were consistently regarded as detrimental to the 
individuals’ satisfaction with treatment. These findings are consistent with previous research 
concerning the quality of care, which report that mental health care can be suboptimal in 
terms of quality and appropriateness (Stein et al., 2011; Young, Klap, Sherbourne, & Wells, 
2001). 
In the current study, many participants also described instances where they felt their 
health professional had not respected their opinions, input and decisions and had divulged 
sensitive information to others. Participants also talked about the quality of the therapy they 
had received, with potentially inappropriate conduct by some health professionals. When this 
occurred, it ruptured rapport and in some instances, deterred participants from completing 
treatment and/or reduced the likelihood of them undertaking it in the future. Malpractice and 
unethical conduct appear to be relatively under-reported in current literature, and prevalence 
rates remain unknown (Moritz et al., 2019). However, researchers acknowledge that these 
forms of practice have existed for decades (Moritz et al., 2019). Clearly, more work needs to 
be undertaken to understand this better. 






Results from this study also established that therapeutic alliance and quality of care 
varied depending on the discipline of the health professional. In particular, participants 
described adverse and/or invalidating experiences with their General Practitioner (GP) where 
they were not offered their preferred treatment, their preference was disregarded, or they 
were not referred to a mental health specialist. This finding is consistent with previous 
research which, for example, found that poor quality care occurred in 80.5% of individuals 
who accessed mental health treatment through their primary care practitioner, compared to 
11.4% accessing it via a mental health specialist (Young et al., 2001). These findings have 
important implications given that most individuals initially seek help via primary care 
settings and practitioners (Young et al., 2001). Moreover, they echo the importance of 
ongoing mental health training and education for primary care practitioners (Acharya, 
Hirachan, Mandel, & van Dyke, 2016).   
Rossom et al. (2016) postulated that individuals who had received patient-centred 
care report higher levels of satisfaction, as they felt more in control of their treatment. In the 
current study, participants strongly endorsed and reported high levels of satisfaction when 
their health professional had comprehensively explained and advised them of the various 
treatment options available before making a collaborative decision. These findings are 
consistent with other research that reported a positive association between shared decision 
making and patient satisfaction (Unützer & Park, 2014). Furthermore, the current study also 
found that individuals reported complete dissatisfaction when they were not involved in 
decisions relating to their treatment or when their treatment was dictated entirely by the 
health professional. These findings reiterate the importance of clinicians practising and 
adhering to patient-centred care.  
The second superordinate theme ‘Experiences with Therapeutic Treatments” 
established in this study encompassed five themes which highlighted patient preferences, 






expectations, satisfaction and readiness for treatment as dominant influencers. Findings 
indicated that individual preferences develop from a multitude of factors including prior 
experience, previous treatment and input or influence from close friends or family. These 
findings corroborate previous research concerning factors that influence an individual’s 
willingness to trial particular treatments (Dunlop et al., 2017; Winter & Barber, 2013). 
Despite clear documentation in the literature and treatment guidelines that advise health 
professionals to consider and/or adhere to patient preferences (Gelhorn et al., 2011; Winter & 
Barber, 2013), many participants in the current study reported that they were not offered their 
preferred treatment and that this subsequently resulted in dissatisfaction and/or discouraged 
them from remaining in treatment. These findings reinforce the notion that client preferences 
play a critical role in initiation, continuation and engagement in treatment, and thus should 
not be overlooked by health professionals (Gelhorn et al., 2011). Health professionals who 
successfully ascertain and acknowledge client preferences have a much greater opportunity to 
positively impact and enhance treatment experiences and potentially the subsequent treatment 
outcomes (Gelhorn et al., 2011).  
Expectations were another reoccurring theme that influenced individuals’ experiences 
with treatment. Interestingly, some participants expressed no particular expectation before 
commencing treatment, as they did not believe anything could change their depression. 
Results also indicated that nominal understanding of treatments corresponded with minimal 
expectations. More specifically, many participants described stereotypical perceptions and 
understandings of treatment such as “lying on a couch” and thus could not comprehend how 
“talking” would help. Previous research asserts that individuals across all clinical contexts 
can develop expectations about treatment and how much they will improve based on the 
information provided to them (Rutherford et al., 2010). Therefore, the findings from the 
current study reiterate the importance of health professionals providing adequate 






psychoeducation to clients. It also confirms that health professionals should endeavour to 
appropriately instil optimism about outcomes to their clients, given that previous research 
stipulates that irrespective of treatment type, expectations about treatment and treatment 
success are the most prominent predictor of outcomes (Rief & Glombiewski, 2017; 
Rutherford et al., 2010).  
The current study also uncovered the dangers of overly ambitious expectations. Some 
participants had a pre-conceived notion that treatment would immediately “remove” their 
depression. Many patients explained that they never anticipated or expected that 
psychotherapy would make them feel worse, be such hard work and take so long. Similarly, 
participants described initially expecting that antidepressants would be a panacea. Across 
both treatment modalities, participants described feeling let down and dissatisfied when their 
expectations did not eventuate. These findings suggest the importance of health professionals 
accurately advising clients of treatment regimens and outcomes, and helping to set realistic 
expectations. Despite this recommendation, advising patients of potential adverse events 
poses a dilemma for health professionals, since it might exert a detrimental effect on 
outcomes and increase the likelihood of an adverse experience resulting (Moritz et al., 2019). 
Therefore, health professionals must tread a careful line between instilling hope in a client by 
emphasising the likely benefits of treatment, while simultaneously appraising them of 
possible risks and/or drawbacks of treatment (Moritz et al., 2019). This requires considerable 
skill by the health professional and again emphasises the importance of adequate education. 
Interviews in the current study indicated that if clients were not “ready” for treatment, 
there was a correspondence with negative experiences and dissatisfaction with treatment. 
Lack of readiness encompassed not wanting to admit they had a problem, not being ready to 
access help, and reduced motivation to successfully engage in or undertake treatment. In 
contrast, participants who were ready to engage in treatment tended to report more positive 






experiences and uptake of treatment. These findings are consistent with the theory of 
readiness to change (Prochaska & DiClemente, 1982), and concur with previous research 
findings which report that individuals who endorse a “high action orientation” respond best to 
treatment irrespective of modality (Lewis et al., 2009). Given that readiness to change is 
understood as a pivotal construct for treatment, it may be useful for health professionals to 
assess readiness to change in individuals with depression to assist in tailoring appropriate 
treatments (Krampe et al., 2017; Lewis et al., 2009). A holistic patient-centred approach that 
includes assessing an individuals readiness for treatment, preparing them to accept treatment 
and communicating realistic treatment expectations may also be important for enhancing 
treatment adherence (Casey, Perera, & Clarke, 2013).  
Participants in the current study reported a myriad of treatment side-effects that 
impacted not only satisfaction but also impeded appropriate utilisation of treatment and 
treatment outcomes. More specifically, many participants explained how they had to take 
additional medication to mitigate adverse side-effects of antidepressants. Moreover, others 
described modifying or ceasing their medication without consulting a doctor due to 
confounding side-effects. These findings are consistent with international studies that report 
many clients cease medication prematurely because of side-effects or other concerns, or take 
medication irregularly and do not follow up with their primary care provider to change 
treatments (Sugarman, 2016; Unützer & Park, 2014). This may be in part because there tends 
to be less intense clinical care and fewer follow-up appointments for individuals taking 
antidepressants (Sugarman, 2016).  
Regardless, in this study, many participants noted the ease and accessibility of 
accessing antidepressants. In contrast, participants described that waitlists and other 
challenges associated with accessing psychotherapy were significant barriers and deterrents 
to therapeutic success. Long waiting times for psychotherapy may serve as a potential 






explanation for individuals increased preferences towards medication (Cartwright, Gibson, 
Read, Cowan, & Dehar, 2016). Furthermore, lower immediate access to psychotherapy may 
necessitate more immediate action by GP’s to prescribe antidepressants (Sreeharan, Madden, 
Lee, Millett, & Majeed, 2013). These findings reinforce the urgency and importance of 
improving availability and access to evidence-based psychological treatment (Patel, 
Chowdhary, Rahman, & Verdeli, 2011).  
Consistent with previous research, participants in the current study reported that 
increased satisfaction with care was related to the provision of quality of care (Stein et al., 
2011). More specifically, participants who received high-quality psychotherapy, including 
perceived competence of the psychologist, were more satisfied with their treatment. 
Satisfaction with treatment has important clinical implications as it is a driver for consumer 
behaviour, treatment efficacy and future engagement (Hasler et al., 2004). In the current 
study, participants reported that their previous experience and satisfaction with treatment 
subsequently influenced the likelihood of them engaging in future treatment and also 
influenced the likelihood of whether they would recommend treatment to others. Given these 
findings, it is critical that clinicians endeavour to provide positive experiences so that 
individuals are not deterred from accessing and engaging in treatment, and similarly do not 
deter others from accessing and engaging in treatment.   
Implications  
Overall, the findings of this study suggest that factors influencing client preferences, 
expectations and satisfaction with treatment for depression are highly individualised and 
complex. It is, therefore, imperative that individual diversity and experience are taken into 
consideration at all stages of treatment. In concordance with previous literature, the current 
study posits the importance of health professionals to consider a range of parameters when 
initially treating clients. This includes attention to depression severity, symptomology and 






longevity of past and recent depressive episodes, as well as the propensity for side-effects for 
available treatment options, and the likelihood of ‘refractoriness to particular treatment 
approaches’ (Kraus et al., 2019, p. 12).  
The current findings have other important implications for health professionals. 
Firstly, it is evident that health professionals and particularly GP’s require a much greater 
understanding of mental health and how to manage it appropriately. Research indicates that 
individuals are more likely to receive mental health care from their primary care provider 
than from a mental health specialist (Unützer & Park, 2014). Given that primary care 
providers are often the “first responders” and the conduit to alternative referral pathways, 
further (and ongoing) training and education in mental health is critical.  
Irrespective of speciality, these findings confirm that health professionals should 
strive to maximise the satisfaction of clients across the health system, and that individual 
client perspectives and experiences should be listened to and taken seriously (Moritz et al., 
2019). These results also advocate for the importance of providing authentic patient-centred 
care and engaging in dual decision-making processes. Health professionals should endeavour 
to elicit and gain information from their client about their experiences and preferences 
relating to various treatment types, and concurrently provide balanced information on all 
treatment options and likely outcomes before collaboratively formulating a treatment 
decision (Raue et al., 2009). While these findings are undoubtedly relevant to current 
practising health professionals, they are also relevant to future health professionals. This 
emphasises the importance of integrating a greater focus on mental health training during 
undergraduate, postgraduate and graduate medical education (Acharya et al., 2016).    
Finally, the findings of this study have important implications for individuals 
experiencing depression. Individuals must be adequately educated about their depression and 
the treatment options available to them. Moreover, the importance and realities of treatment 






need to be emphasised, and individuals should be supported throughout their journey via 
regular contact with treating health professionals (Casey et al., 2013). 
Strengths, Limitations and Future Research  
This study has provided significant insight into the preferences, expectations, lived 
experiences and satisfaction of individuals who had engaged in pharmacotherapy or 
psychotherapy for depression, and provides a much-needed contribution to the relatively 
limited qualitative literature within this area. A strength of the current study was that it 
included a relatively large and diverse array of participants. A qualitative design and 
methodology that used semi-structured interview questions was pertinent to the exploratory 
nature of the research aim. Moreover, study participants were open and forthcoming with in-
depth information, thus resulting in an extremely rich data set to inform the results.  
Like any research, this study has several limitations that should be considered. While 
the sample was relatively large and diverse, all participants were from South Australia and 
thus cannot be expected to be representative of all individuals’ experiences of depression. 
While diversity is advantageous, without segmentation that diversity may also have created 
greater variability in responses received and inhibit elucidation of potentially important 
cohort trends (i.e. male/female, age-related etc.).  
Analysis of the sample indicates that more women than men participated in this study. 
This is consistent with previous literature which asserts that men are often reticent to seek 
help and engage in treatment for depression (Seidler, Rice, Oliffe, Fogarty, & Dhillon, 2018). 
Given the high rates of suicide in males, and the increasing propensity of underreporting and 
underdiagnosing of mental health conditions in men (Seidler, Dawes, Rice, Oliffe & Dhillon, 
2016), future research could therefore consider further exploring men’s experience of help-
seeking and engagement in treatment. Such research could play an important role in 






improving understanding as well as increase help-seeking behaviours and engagement in 
treatment for men experiencing depression (Seidler et al., 2016).  
There was also a lack of cultural diversity among participants, and the generalisability 
of the findings from this study should, therefore, be considered in that context. Depression 
and mental health more broadly can be culturally dependent, and thus future research might 
consider similar studies that explicitly consider culturally diverse populations and various 
demographic cohorts.   
The current study was also not able to account for the high prevalence of comorbidity 
and poly-treatment modalities that became evident. Future research may, therefore, aim to 
examine depression without the presence of comorbidities and/or examine individuals 
experiences when only one form of treatment has occurred (i.e. only psychotherapy or only 
pharmacotherapy). However, there needs to be consideration of whether this is necessarily 
realistic in contexts other than randomised control trials.   
The current study relied on a self-selected sample, and it could, therefore, be argued 
that the higher rates of adverse experiences resulted from a somewhat biased sample. 
However, many participants explained that they wanted to share their experiences to promote 
and elicit change. Finally, future research may consider exploring the views and opinions of 
health professionals. Triangulation of individuals and their health professionals’ opinions and 
experiences would strengthen the credibility of findings.  
Conclusion  
The occurrence and impact of depression continue to escalate despite significant 
attention to this debilitating disorder. There is a clear need for targeted research on this topic, 
particularly in relation to understanding patient experiences. The present study thus makes a 
valuable contribution to the literature. It not only addresses gaps in our knowledge but also 
provides important recommendations that will enhance clinical practice and approaches to 






treatment. There are several unique contributions of this study. One was the elucidation of the 
criticality of education for current and emerging primary health care practitioners, as well as 
specialists in mental health. The study also uncovered the importance of taking into account a 
clients’ perspectives and preferences, and the need for health professionals to acknowledge 
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